- Home
- RVLV vs KNSA Comparison
RVLV vs KNSA Comparison
Compare RVLV & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVLV
- KNSA
- Stock Information
- Founded
- RVLV 2003
- KNSA 2015
- Country
- RVLV United States
- KNSA United Kingdom
- Employees
- RVLV N/A
- KNSA N/A
- Industry
- RVLV Catalog/Specialty Distribution
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- RVLV Consumer Discretionary
- KNSA Health Care
- Exchange
- RVLV Nasdaq
- KNSA Nasdaq
- Market Cap
- RVLV N/A
- KNSA 1.6B
- IPO Year
- RVLV 2019
- KNSA 2018
- Fundamental
- Price
- RVLV $22.27
- KNSA $23.09
- Analyst Decision
- RVLV Buy
- KNSA Strong Buy
- Analyst Count
- RVLV 14
- KNSA 6
- Target Price
- RVLV $30.93
- KNSA $37.17
- AVG Volume (30 Days)
- RVLV 1.4M
- KNSA 634.6K
- Earning Date
- RVLV 05-06-2025
- KNSA 04-22-2025
- Dividend Yield
- RVLV N/A
- KNSA N/A
- EPS Growth
- RVLV 81.03
- KNSA N/A
- EPS
- RVLV 0.70
- KNSA N/A
- Revenue
- RVLV $1,129,911,000.00
- KNSA $423,239,000.00
- Revenue This Year
- RVLV $11.25
- KNSA $37.21
- Revenue Next Year
- RVLV $2.94
- KNSA $1.38
- P/E Ratio
- RVLV $31.72
- KNSA N/A
- Revenue Growth
- RVLV 5.73
- KNSA 56.60
- 52 Week Low
- RVLV $14.88
- KNSA $16.56
- 52 Week High
- RVLV $39.58
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- RVLV 37.78
- KNSA 60.12
- Support Level
- RVLV $20.83
- KNSA $22.62
- Resistance Level
- RVLV $23.85
- KNSA $23.42
- Average True Range (ATR)
- RVLV 1.20
- KNSA 0.75
- MACD
- RVLV 0.27
- KNSA -0.01
- Stochastic Oscillator
- RVLV 31.86
- KNSA 68.88
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.